Savara
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
CEOMatthew Pauls
CEOMatthew Pauls
Employees59
Employees59
HeadquartersLanghorne, Pennsylvania
HeadquartersLanghorne, Pennsylvania
Founded1995
Founded1995
Employees59
Employees59
SVRA Key Statistics
Market cap755.40M
Market cap755.40M
Price-Earnings ratio-8.50
Price-Earnings ratio-8.50
Dividend yield—
Dividend yield—
Average volume1.68M
Average volume1.68M
High today$4.41
High today$4.41
Low today$4.12
Low today$4.12
Open price$4.16
Open price$4.16
Volume1.61M
Volume1.61M
52 Week high$4.42
52 Week high$4.42
52 Week low$1.89
52 Week low$1.89
SVRA News
TipRanks 4d
Savara price target raised to $11 from $8 at Citizens JMPCitizens JMP raised the firm’s price target on Savara (SVRA) to $11 from $8 and keeps an Outperform rating on the shares. The firm’s pulmonologist survey indica...
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SVRA. This list is generated using Robinhood data, and it’s not a recommendation.